U.S. CDC recommends Novavax COVID vaccine for adults
Go back to U.S. CDC recommends Novavax COVID vaccine for adults| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.32 -0.12 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.44 | 52 Week High | $9.23 | |||
| Open | $9.33 | 52 Week Low | $1.16 | |||
| Day High | $9.44 | P/E | N/A | |||
| Day Low | $9.26 | EPS | $-0.30 | |||
| Volume | 261,219 | |||||

